Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

Most follicular lymphoma cases exhibit classic clinicopathologic ... such as establishing the histologic grade and excluding a component of diffuse large B-cell lymphoma (DLBCL), she adds.

A 2012 study of patients with low-tumor-burden follicular lymphoma showed that the 4-year freedom from treatment failure rate of watch-and-wait patients was not inferior to that o ...

Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.

CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma ... Technology is helping to clarify how low-grade lymphoma changes as it develops into a more ...

Follicular lymphoma is an indolent malignancy ... "These patients should require the usual treatment for high-grade lymphoma, usually with an anthracycline-based regimen, if they didn't receive ...

The new use is the third for Kymriah (tisagenlecleucel) in the EU and offers patients with grade 1, 2 and 3A follicular lymphoma that has returned after two or more prior treatments a new ...